# Elixiron Immunotherapeutics

**Canonical:** https://apis.io/providers/elixiron-immunotherapeutics/  
**Website:** https://elixiron.com/  
**APIs profiled:** 0

Elixiron Immunotherapeutics (Cayman) Limited is a clinical-stage biopharmaceutical company founded in 2017, with offices in Taipei, Taiwan and Cambridge, Massachusetts, developing precision immunotherapies for neuroinflammation, autoimmune disease and cancer. Its clinical pipeline is led by enrupatinib (EI-1071), a small-molecule CSF-1R inhibitor in development for Alzheimer's disease and other neurodegenerative indications, and EI-001, a fully human anti-interferon-gamma monoclonal antibody in Phase 2 for vitiligo, alongside preclinical EI-012 (anti-CD36) and EI-220 (mRNA) oncology programs. The company publishes a corporate and investor-relations website only: there is no developer portal, public API, SDK, webhook surface or machine-readable specification of any kind on its own hosts.

## Kin Score — 4.1 / 100 (minimal)

Scored 2026-08-19 under rubric 0.12.0. Trend: flat (-1.9 from 6.0).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Elixiron Immunotherapeutics Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biotechnology, Pharmaceuticals, Immunotherapy, Life Sciences, Clinical Trials, Healthcare, Taiwan

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/elixiron-immunotherapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.